Scientific Programme & Abstracts from the International Meeting in Pediatric Endocrinology (IMPE)

impe0096p101 | Growth and Syndromes | IMPE2023

A prospective genetic analysis of children with idiopathic short stature (ISS) using whole-exome sequencing (WES): first results

P Cellin Laurana , L M Andrade Nathalia , C Rezende Raissa , de Souza Vinícius , C B Dantas Naiara , P S Quedas Elisangela , F A Funari Mariana , A Vasques Gabriela , C Scalco Renata , A C Malaquias Alexsandra , A L Jorge Alexander

Introduction: Children classified as idiopathic short stature (ISS) may have a monogenic cause that can explain their growth disorder. In this context, genetic tests emerge as a new diagnostic tool. Objectives: To determine the usefulness of WES for the genetic investigation of children with ISS.Patients and Methods: We sequentially enrolled 95 children with ISS without previous genetic testing, except for karyotyping fo...

impe0096fc5.3 | Fat, Metabolism and Obesity | IMPE2023

Development of Novel Anorexigenic and Glucoregulatory Chimeric Peptides

L. Roth Christian , S. Chichura Kylie , R. Sweet Ian , Elfers Clinton , Berry Dustin , T. Milliken Brandon , P. Doyle Robert

Mechanisms underlying long-term sustained weight loss and glycemic normalization after obesity surgery involves changes in gut hormone levels, including glucagon-like peptide 1 (GLP-1) and peptide YY (PYY). Designing dual or triple agonists based on glucagon-like peptide (GLP)-1 with glucagon, and/or glucose-dependent insulinotropic polypeptide (GIP) are promising novel approaches for anti-obesity drugs tackling different weight-regulatory pathways, albeit such developments co...

impe0096p53 | Fat, Metabolism and Obesity | IMPE2023

Heterozygous Rare Sequence Variants In Genes of The Leptin-Melanocortin Pathway are Highly Prevalent in Childhood Obesity But Do Not Associate with Distinctive Phenotypic Features

Ángel Martos-Moreno Gabriel , Guijo-Alonso Blanca , Alberto Pérez-Jurado Luis , Argente Jesús

Background: The central melanocortin system is involved in metabolic control, receiving, and integrating metabolic signals, such as leptin. Biallelic mutations in several genes of this pathway have been reported in severe obesity. However, whether and how heterozygous rare sequence variants (hetRSVs) in genes of the melanocortin system contribute to the development of obesity is poorly explored.Objectives: To explore the...

impe0096p57 | Fat, Metabolism and Obesity | IMPE2023

Differential metabolomic changes in response to saturated and unsaturated fatty acids

Collado- Pérez Roberto , María Jiménez María , Argente Jesús , M. Frago Laura , A. Chowen Julie

Background: Healthy living, as well as treatment of overweight and obesity, includes a trend towards personalized diets. To better design these diets, predicting an individual’s metabolic response to specific nutrients is necessary and to do so we must understand how nutrients are perceived by metabolic circuits and to identify the signals involved. Moreover, as males and females respond differently to an obesogenic environment, how energy perception dif...

impe0096fc2.1 | Fetal and Neonatal Endocrinology | IMPE2023

Increased catecholamines link fetal stress or growth restriction and neonatal hyperinsulinemic hypoglycemia: a prospective cohort study

Hoermann Henrike , van Faassen Martijn , Roeper Marcia , Hagenbeck Carsten , Herebian Diran , C. Muller-Kobold Anneke , Dukart Juergen , P. Kema Ido , Mayatepek Ertan , Meissner Thomas , Kummer Sebastian

Background: Perinatal stress, fetal growth restriction (FGR) or being small for gestational age (SGA) poses a high risk for neonatal hypoglycemia. The exact pathomechanism is unknown. In an animal model, increased levels of catecholamines were found in FGR sheep, causing β-cell adaptation with suppressed intrauterine insulin secretion, subsequently resulting in a hyper-responsive insulin secretion once the adrenergic stimulus subsides, e.g. after birth. W...

impe0096fc3.4 | Endocrinology of Sex Differences 1 | IMPE2023

The combination of FSH and markers of Sertoli cell function provides a high accuracy strategy to differentiate central hypogonadism from constitutional delay of puberty in boys: a longitudinal prospective study.

Castro Sebastián , Correa Brito Lourdes , Bedecarrás Patricia , Gabriela Ropelato María , Keselman Ana , Cassorla Fernando , Bergadá Ignacio , A Rey Rodolfo , P Grinspon Romina

Constitutional delay of puberty (CDP) and congenital central hypogonadism (CH) show great overlap in clinical features and in gonadotrophin and testosterone serum concentrations in boys. The gold standard to distinguish both entities relies on the assessment of pubertal stage beyond 18 years of age. The long lasting insufficient FSH activity in boys with congenital CH may result in lower AMH and inhibin B serum concentrations compared with boys with CDP....

impe0096p98 | Growth and Syndromes | IMPE2023

Girls with short statute and Xp22;Yq11 translocation: should a prophylactic gonadectomy be recommended?

C.B. Dantas Naiara , F.A. Funari Mariana , L.M. Andrade Nathalia , C. Rezende Raíssa , P. Cellin Laurana , G. Crisostomo Lindiane , C. Scalco Renata , A.L. Jorge Alexander

Background: Translocations involving the X and Y chromosome are rare in humans. Here we describe two cases diagnosed during the investigation of short stature. Case 1: She was born at 38 gestational weeks (GW), with birth weight (BW) SDS -1.5 and birth length (BL) SDS -2.7. At the first assessment, she had a chronological age (CA) of 11.3ys, a height SDS of -2.2, a sitting height-to-height SDS of 4.6, and Madelung´s deformity. The height SDS of her mothe...

impe0096fc7.1 | Bone and Growth | IMPE2023

Encaleret (CLTX-305) Normalized Mineral Homeostasis Parameters in Patients with Autosomal Dominant Hypocalcemia Type 1 over 12 months in a Phase 2 Study (NCT04581629)

I Gafni Rachel , R Hartley Iris , L Roszko Kelly , F Nemeth Edward , A Pozo Karen , P Boykin Winsome , S Mathew Arun , Scott Roberts Mary , H Adler Scott , T Collins Michael

Autosomal dominant hypocalcemia type 1 (ADH1), caused by gain-of-function variants in the calcium-sensing receptor (CaSR) gene, is characterized by low parathyroid hormone (PTH), hypocalcemia, hypercalciuria, hyperphosphatemia, and hypomagnesemia. Patients usually present in childhood, at a median age of 4y, often with severe symptoms of hypocalcemia. Conventional therapy (calcium and active vitamin D) worsens hypercalciuria and can lead to renal morbidity. Calcilytics that ac...

impe0096p143 | Sex Differentiation, Gonads and Gynaecology, and Sex Endocrinology | IMPE2023

Ovarian cell dysfunction at diagnosis in girls with haematological malignancies

Lopez Dacal Jimena , Prada Silvina , Arcari Andrea , Freire Analia , Gryngarten Mirta , Gabriela Ropelato Maria , Gabriela Ballerini Maria , Eugenia Rodriguez Maria , Gutierrez Marcela , Soria Marcela , Morán Lorena , E. Ferraro Cristina , Bedecarrás Patricia , Drelichman Guillermo , Aversa Luis , Bergadá Ignacio , A. Rey Rodolfo , P. Grinspon Romina

Introduction: Haematological malignancies represent the most frequent childhood cancer. Little is known about small ovarian follicle function at diagnosis in girls with acute lymphoblastic leukaemia (ALL), acute myeloid leukaemia (AML) or non-Hodgkin lymphoma (NHL). AMH is a useful marker of small follicles.Aim: To determine small ovarian follicle status at diagnosis and after 3 months of chemotherapy in girls and adoles...